EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2

PloS One
Wael H RoshdyMohamed A Ali

Abstract

Due to the challenges for developing vaccines in devastating pandemic situations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), developing and screening of novel antiviral agents are peremptorily demanded. Herein, we developed EGYVIR as a potent immunomodulatory herbal extract with promising antiviral activity against SARS-CoV-2. It constitutes of a combination of black pepper extract with curcumin extract. The antiviral effect of EGYVIR extract is attributed to the two key phases of the disease in severe cases. First, the inhibition of the nuclear translocation of NF-kβ p50, attenuating the SARS-CoV-2 infection-associated cytokine storm. Additionally, the EGYVIR extract has an in vitro virucidal effect for SARS-CoV-2. The in vitro study of EGYVIR extract against SARS-CoV-2 on Huh-7 cell lines, revealed the potential role of NF-kβ/TNFα/IL-6 during the infection process. EGYVIR antagonizes the NF-kβ pathway in-silico and in-vitro studies. Consequently, it has the potential to hinder the release of IL-6 and TNFα, decreasing the production of essential cytokines storm elements.

References

Mar 1, 1974·Journal of Pharmaceutical Sciences·G S Rao, J E Sinsheimer
Oct 1, 1980·Antimicrobial Agents and Chemotherapy·F G HaydenR Simons
Sep 19, 2003·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·A SchuhmacherP Schnitzler
Oct 7, 2004·Chemical & Pharmaceutical Bulletin·Tomonori TanakaToshihiro Nohara
Mar 16, 2006·Toxicological Sciences : an Official Journal of the Society of Toxicology·Jun CaoLai-Fu Zhong
Jul 25, 2008·Nature·Ruslan Medzhitov
Feb 18, 2009·Archives of Otolaryngology--head & Neck Surgery·Alen N CohenMarilene B Wang
Sep 3, 2009·Annals of the New York Academy of Sciences·Simone ReuterMarc Diederich
Dec 2, 2010·Life Sciences·Hifzur Rahman Siddique, Mohammad Saleem
Aug 9, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Suejung G KimMarilene B Wang
Sep 20, 2012·Bioorganic & Medicinal Chemistry·M MayadeviR V Omkumar
Nov 13, 2012·The AAPS Journal·Subash C GuptaBharat B Aggarwal
May 10, 2013·PloS One·Tzu-Yen ChenWei-Li Hsu
Feb 13, 2014·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Sahdeo PrasadBharat B Aggarwal
Apr 19, 2015·Respiratory Research·Yali ZhangGuang Liang
Dec 8, 2015·Experimental and Therapeutic Medicine·Donatella PerroneLorenzo Lo Muzio
Apr 3, 2016·Current Protocols in Molecular Biology·Oliver Fiehn
Jul 10, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Giuseppe DerosaAmirhossein Sahebkar
Oct 25, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Minji YangGwangPyo Ko
Feb 22, 2017·Arthritis & Rheumatology·Edward M Behrens, Gary A Koretzky
Mar 28, 2017·Antiviral Research·Bryan C MounceMarco Vignuzzi
Aug 31, 2017·Clinical and Experimental Pharmacology & Physiology·Shuguang HanMao Huang
Dec 1, 2017·Journal of Restorative Medicine·Shusuke Toden, Ajay Goel
Sep 19, 2019·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Boya ZhangMadathilparambil V Suresh
Jan 26, 2020·Journal of Medical Virology·Geng LiJianguo Wu
Apr 14, 2020·The Journal of Infection·Qing YeJianhua Mao

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
PCR
enzyme-linked immunosorbent assay
nuclear translocation

Software Mentioned

SwissDock
EA Docking
CHARMM22
UCSF Chimera
EGYVIR

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.